Strongyloides stercoralis: A rare cause of obstructive duodenal stenosis

Digestion

Volumn 77, Issue 3-4, 2008, Pages 141-144

  Juchems, Markus S ^a   Niess, Jan Hendrik ^a   Leder, Gerhard ^a   Barth, Thomas F ^a   Adler, Guido ^a   Brambs, Hans Juergen ^a   Wagner, Martin ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Duodenal obstruction; Helminthic infection; Strongyloides stercoralis

Indexed keywords

PANTOPRAZOLE;

ADULT; ARTICLE; BIOPSY; CASE REPORT; CHOLEDOCHOJEJUNOSTOMY; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; DUODENUM OBSTRUCTION; DUODENUM STENOSIS; ENTEROCOLITIS; EOSINOPHIL; FOOD INTAKE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MUCOSA; NAUSEA; PARENTERAL NUTRITION; PRIORITY JOURNAL; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; VOMITING;

ANIMALS; ANTIPARASITIC AGENTS; CONSTRICTION, PATHOLOGIC; DILATATION, PATHOLOGIC; DUODENAL OBSTRUCTION; DUODENUM; ENDOSCOPY, GASTROINTESTINAL; ENDOSONOGRAPHY; HUMANS; IVERMECTIN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NAUSEA; STOMACH; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VOMITING;

EID: 50149119677     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000128597     Document Type: Article

References (20)

1. Concha R, Harrington W, Rogers AI: Intestinal strongyloidiases: recognition, management and determinants of outcome. J Clin Gastroenterol 2005;39:203-211.
2. Lim S, Katz K, Krajden S, et al: Complicated and fatal Strongyloides infections in Canadians: risk factors, diagnosis and management. CMAJ 2004;171:479-484.
3. Keiser PB, Nutmann TB: Strongyloides sterocalis in the immunocompromised population. Clin Microbiol Rev 2004;17:208-217.
4. Liepman M: Disseminated Strongyloides stercoralis. A complication of immunosuppression. JAMA 1975;231:387-388.
5. Siddiqui AA, Berk SL, Genta RM: Strongyloidiasis; in Guerrant RL, Walker DH, Weller RF (eds): Tropical Infectious Diseases. Philadelphia, Elsevier, 2005, pp 1274-1285.
6. Weller PF, Nutman TB: Intestinal nematodes; in Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL (eds): Harrisons's Principles in Internal Medicine. New York, McGraw Hill, 2005, pp 1256-1260.
7. von Kuster LC, Genta RM: Cutaneous manifestation of strongyloidiasis. Arch Dermatol 1988;124:1826-1830.
8. Smith JD, Goette DK, Odom RB: Larva currens. Cutaneous strongyloidiasis. Arch Dermatol 1976;112:1161-1163.
9. Milder JE, Walzer PD, Kilgore G, et al: Clinical features of Strongyloides sterocalis infection in an endemic area of the United States. Gastroenterology 1981;80:1481-1488.
10. Vadlamudi RS, Chi DS, Krishnaswamy G: Intestinal strongyloidiasis and hyperinfections syndrome. Clin Mol Allergy 2006;4:8.
11. Neva FA: Intestinal nematodes in human beings; in Neva FA (ed): Basic Clinical Parasitology. Norwalk, Appleton &Lange, 1994, pp 123-128.
12. Mansfield LS, Alavi A, Wortman JA, et al: Gamma camera scintigraphy for direct visualization of larval migration in Strongyloidis infected dogs. Am J Trp Med Hyg 1995;52:236-240.
13. Grove DI: Clinical manifestations;in Grove DI (ed): Strongyloidiasis: A Major Roundworm Infection of Man. Philadelphia, Taylor & Friends, 1989, pp 155-173.
14. Niess JH, Reinecker HC: Dendritic cells in intestinal antigen uptake pathways. Cell Microbiol 2006;8:558-564.
15. Podolsky DK: Inflammatory bowel disease. N Engl J Med 2002;347:417-429.
16. Kulke MH, Mayer RJ: Carcinoid tumors. N Engl J Med 1999;340:858-868.
17. Rudolph P, Chiaravalli AM, Pauser U, et al: Gastrointestinal mesenchymal tumors - immunophenotypic classification and survival analysis. Virchows Arch 2002;441:238-248.
18. Kim JH, Kim MJ, Chung JJ, et al: Differential diagnosis of periampullary carcinomas at MR imaging. Radiographics 2002;22:1335-1352.
19. Pitisuttithum P, Supanaranond W, Chindanond D: A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. Southeast Asian J Trp Med Public Health 1995;26:735-738.
20. Gann PH, Neva FA, Gam AA: A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994;169:1076-1079.